Cell MedX Corp (OTCMKTS:CMXC) was down 2.9% on Tuesday . The company traded as low as $0.31 and last traded at $0.33, approximately 58,278 shares traded hands during trading. A decline of 9% from the average daily volume of 64,128 shares. The stock had previously closed at $0.34.
The business has a 50-day simple moving average of $0.50 and a two-hundred day simple moving average of $0.41.
About Cell MedX (OTCMKTS:CMXC)
Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, and high blood pressure. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications.
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.